Boardroom Alpha
Boardroom Alpha
FVN · Current Report (Form 8-K) · Filed July 27, 2026

Future Vision II Acquisition Corp — Current Report (Form 8-K)

Form
8-K
Filed
July 27, 2026
Period
Jul 23, 2026
Ticker
FVN
Accession
0001829126-26-007886
Boardroom Alpha · Filing insights

Shareholders approved the Business Combination and Name Change; 3,758,515 shares were tendered for cash redemption.

About Future Vision II Acquisition Corp
Market cap
$71M
1Y TSR
+9.9%
Sector
Industrials
CEO
Xiaodong Wang
Last annual meeting: Aug 21, 2026 · View full Future Vision II Acquisition Corp profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 23, 2026

 

 

 

Future Vision II Acquisition Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-42273   00-0000000N/A

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

Xiandai Tongxin Building

201 Xin Jinqiao Road, Rm 302

Pudong New District

Shanghai, China00000

(Address of principal executive offices, including zip code)

 

+ (86) 136 0300 0540

(Registrant’s telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Ordinary Share, par value $0.0001 per share, and one right to acquire 1/10th of one Ordinary Share   FVNNU   The Nasdaq Stock Market LLC
Ordinary Shares included as part of the Units   FVN   The Nasdaq Stock Market LLC
Rights included as part of the Units   FVNNR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

On July 23, 2026, Future Vision II Acquisition Corp. (the “Company”) held an extraordinary general meeting of shareholders (the “Meeting”). As of June 15, 2026, the record date for the Meeting, there were 7,544,000 ordinary shares of the Company issued and outstanding and entitled to vote. At the Meeting, there were 5,812,556 ordinary shares present in person or represented by proxy, representing approximately 80.593% of the total outstanding ordinary shares entitled to vote, which constituted a quorum to conduct business.

 

The shareholders of the Company voted on the following proposals, which were described in detail in the definitive proxy statement/prospectus filed with the Securities and Exchange Commission. The final voting results for each proposal are set forth below.

 

Proposal 1: The Business Combination Proposal. The shareholders approved by ordinary resolution the Merger Agreement and the transactions contemplated therein. The voting results were as follows:

 

Votes For: 5,688,865

 

Votes Against: 123,691

 

Abstentions: 0

 

Proposal 2: The Name Change Proposal. The shareholders approved by special resolution the change of name from “Future Vision II Acquisition Corp.” to “MicroTouch Inc.” (or another determined name) upon the consummation of the Business Combination, subject to the approval of the Registrar of Companies of the Cayman Islands, and authorized the registered office provider and directors to give effect to this resolution. The voting results were as follows:

 

Votes For: 5,688,865

 

Votes Against: 123,691

 

Abstentions: 0

 

Proposal 3: The Nasdaq Proposal. The shareholders approved by ordinary resolution, for the purposes of complying with applicable provisions of Nasdaq Rule 5635, the issuance of Future Vision ordinary shares in connection with the Business Combination. The voting results were as follows:

 

Votes For: 5,688,865

 

Votes Against: 123,691

 

Abstentions: 0

 

Proposal 4: The Charter Amendment Proposal. The shareholders approved by special resolution the adoption of the amended and restated memorandum and articles of association, effective from the completion of the Business Combination, to reflect the Name Change Proposal and remove or amend provisions applicable only prior to the consummation of the Business Combination. The voting results were as follows:

 

Votes For: 5,489,514

 

Votes Against: 323,042

 

Abstentions: 0

 

1

 

 

Proposal 5: The Director Election Proposal. The shareholders approved by ordinary resolution the election of the following five individuals to serve as directors on the board of directors of the Company upon the consummation of the Business Combination. The voting results were as follows:

 

Aijiao Tian: 5,688,865 Votes For, 123,691 Votes Withheld

 

Jinyan Han: 5,688,865 Votes For, 123,691 Votes Withheld

 

Kai Lun Wong: 5,688,865 Votes For, 123,691 Votes Withheld

 

Shuding Zeng: 5,688,865 Votes For, 123,691 Votes Withheld

 

Maria Borg: 5,688,865 Votes For, 123,691 Votes Withheld

 

Proposal 6: The Adjournment Proposal. The shareholders approved by ordinary resolution the adjournment of the Meeting, if necessary or advisable, in the event the Company did not receive the requisite shareholder vote to approve one or more proposals presented to shareholders for vote. The voting results were as follows:

 

Votes For: 5,688,865

 

Votes Against: 123,691

 

Abstentions: 0

 

Item 8.01.Other Events.

 

Redemption of Ordinary Shares

 

In connection with the extraordinary general meeting of shareholders held on July 23, 2026 (the “Meeting”), holders of the Company’s public ordinary shares were provided the opportunity to tender their shares for cash redemption.

 

A total of 3,758,515 public ordinary shares were validly tendered for redemption. The redemption of these tendered shares, and the subsequent disbursement of the corresponding funds from the Company’s trust account, is expressly conditioned upon the legal consummation of the Business Combination.

 

Had the Business Combination closed contemporaneously with the Meeting, the redemption price would have been approximately $10.97 per share, representing an estimated aggregate redemption payment of approximately $41,228,654.43. However, in accordance with Article 37.6 of the Company’s Amended and Restated Memorandum and Articles of Association, the final per-share redemption price payable to redeeming shareholders will be calculated as of two business days prior to the actual consummation of the Business Combination. As a result, the final per-share payout may be higher than the current estimate due to continued interest accrual and at the option of the Company's sponsor to deposit extension loans into the trust account until the Business Combination is consummated.

 

The consummation of the Business Combination remains subject to the satisfaction or waiver of various closing conditions set forth in the Merger Agreement, including, but not limited to, the Company obtaining initial listing approval from Nasdaq. There can be no assurance as to when these closing conditions will be satisfied, or if they will be satisfied at all.

 

2

 

 

If the closing conditions are not met and the Business Combination is not consummated, the 3,758,515 validly tendered shares will not be redeemed for cash, the redemption requests will be canceled, and the shares will remain outstanding.

 

Furthermore, if the consummation of the Business Combination is significantly delayed, the Company may be required to hold a separate extraordinary general meeting of shareholders to further extend the date by which it must complete a business combination (an “Extension Meeting”), or otherwise be forced to liquidate and dissolve. If the Company convenes an Extension Meeting, public shareholders will be provided a new, independent opportunity to redeem their public ordinary shares for a pro-rata portion of the trust account. Unlike redemptions tendered in connection with the Business Combination, which are contingent upon Closing, redemptions validly tendered in connection with an Extension Meeting would be paid out promptly following the shareholder approval and legal effectuation of the charter amendment to extend the deadline, regardless of whether the Business Combination is ultimately consummated. Alternatively, if the Company is forced to liquidate and dissolve without completing a business combination, all outstanding public ordinary shares will be automatically canceled in exchange for a pro-rata distribution of the funds held in the trust account, in accordance with the Company’s amended and restated memorandum and articles of association.

 

Assuming the eventual satisfaction of all closing conditions and the consummation of the Business Combination, following the effectuation of these redemptions, 1,991,485 public ordinary shares will remain outstanding, and an aggregate of approximately $21,845,460.57 will remain in the Company’s trust account (subject to final adjustment based on the actual Closing Date). Prior to giving effect to the issuance of the consideration shares and the automatic conversion of outstanding rights in connection with the closing of the Business Combination, the Company expects to have 3,785,485 total ordinary shares issued and outstanding following the payment of the redemptions. 

 

Item 9.01.Financial Statements and Exhibits.

 

Exhibit No.   Description of Exhibits
3.1   Amended and Restated Articles and Restated Memorandum and Articles of Association effective September 11, 2024, incorporated by reference to 8-K filed on September 12, 2024 
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Future Vision II Acquisition Corp.
     
Date: July 27, 2026 By: /s/ Danhua Xu
  Name: Danhua Xu
  Title: CEO and Director

 

4

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Future Vision II Acquisition Corp (FVN)

Reference

Frequently asked questions

When did Future Vision II Acquisition Corp file this 8-K?
Future Vision II Acquisition Corp (FVN) filed this Current Report (Form 8-K) with the SEC on July 27, 2026. The accession number assigned by EDGAR is 0001829126-26-007886.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved the Business Combination and Name Change; 3,758,515 shares were tendered for cash redemption. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Future Vision II Acquisition Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Future Vision II Acquisition Corp has filed under CIK 2010653, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer